AMIODARONE THYROTOXICOSIS IN A PATIENT WITH HYPERTROPHIC CARDIOMYOPATHY
A clinical observation of amiodarone thyrotoxicosis in a patient with hypertrophic cardiomyopathy is presented.
Saved in:
Main Authors: | P. Kh. Dzhanashiya, E. V. Avdeeva, N. S. Krylova, S. A. Nikolenko, V. A. Nazarenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2009-06-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1354 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unmarked Case of Amiodarone-Induced Thyrotoxicosis
by: N. I. Volkova, et al.
Published: (2011-09-01) -
IVABRADIN AND ATENOLOL EFFECTIVENESS COMPARISON IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
by: P. Kh. Dzhanashiya, et al.
Published: (2010-02-01) -
CARDIAC ARRHYTHMIAS IN MEDICAL PRACTICE: CLINICAL CASE OF AMIODARONE-INDUCED THYROTOXICOSIS TYPE 2 AS A CAUSE OF RECURRENT ATRIAL FIBRILLATION
by: O. V. Gaisenok
Published: (2016-01-01) -
ENDOCRINE ASPECTS OF AMIODARONE THERAPY IN CLINICAL PRACTICE (FOLLOW-UP AND TREATMENT ALGORITHM FOR PATIENTS WITH THYROID DYSFUNCTION)
by: N. Yu. Sviridenko, et al.
Published: (2012-04-01) -
THE USE OF AMIODARONE IN CLINICAL PRACTICE: THE PROBLEM OF SIDE EFFECTS
by: O. V. Gaisenok
Published: (2016-01-01)